The injection should be administered once weekly on the same day each week, though the specific time of day can be flexible based on patient preference and lifestyle factors
Rouette J, Yin H, Yu OHY, Bouganim N, Platt RW, Azoulay L
A: Some advanced protocols do, but overlap increases complexity and risk
Lixisenatide (Lyxumia) is a daily GLP-1 receptor agonist available in the UK
Domperidone and metoclopramide have MHRA restrictions due to cardiac and neurological risks respectively, and should be used at the lowest effective dose for the shortest duration
In order to allow a more sensitive differentiation of GLP-1 RA-dependent HR effects, the current manuscript presents HR data derived from ECG measurements and ambulatory blood pressure monitoring at multiple time points over 24 h